New data from the REAL-PE analysis investigated catheter-based pulmonary embolism (PE) treatment, showing women and Black ...

Mechanical thrombectomy (MT), another invasive treatment method has been shown to reduce thrombus burden and pulmonary artery ...

Beth Slaunwhite was diagnosed with pulmonary hypertension (PH) after years of being misdiagnosed and struggling with ...

mitochondrial abnormalities and thrombosis are the dominant underlying pathobiologic processes of pulmonary arterial hypertension (PAH). In addition to conventional and supportive therapies ...

A pulmonary embolism is a blockage in the pulmonary artery that supplies blood to the lungs. The blockage, usually caused by a blood clot, impairs oxygenation of the blood and can damage the heart.

Share on Pinterest After years of living with worsening symptoms from pulmonary arterial hypertension, Heather Kauffman’s (right) life changed when she joined a clinical trial for the new ...

For pulmonary arterial hypertension, currently marketed methods of treprostinil administration include intravenous, subcutaneous and inhalation. Oral treprostinil is actively being investigated.

Over 150 experts and patient representatives from across globe came together at Ferrer’s IMPAHCT conference 2024 to address ...

The approval, which marks the first for a once-daily, single-tablet combination therapy for pulmonary arterial hypertension, is based on findings from the phase 3 A DUE study. About 17 million ...

Merck on Thursday reported first-quarter results that beat analysts’ expectations amid strong sales of vaccines and cancer ...

Report Ocean’s latest analysis delves into the “Vietnam Pulmonary Arterial Hypertension Market” Report from 2024 to 2032, ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) ...